Anandamide

• Nightmares and the Cannabinoids (26 Sep 2024)
  
• The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020 (16 Sep 2024)
  
• Omega-6 and omega-3 fatty acids: Endocannabinoids, genetics and obesity (16 Sep 2024)
  
• Different Effects of Cannabis Abuse on Adolescent and Adult Brain (16 Sep 2024)
  
• Changing the Tone of Clinical Study Design in the Cannabis Industry (16 Sep 2024)
  
• Cannabinoids and triple-negative breast cancer treatment (03 Sep 2024)
  
• Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine (02 Sep 2024)
  
• The Relationship between Muscarinic and Cannabinoid Receptors in Neuronal Excitability and Epilepsy: A Review (02 Sep 2024)
  
• The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease (02 Sep 2024)
  
• Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs (02 Sep 2024)
  
• Role of the CB2 Cannabinoid Receptor in the Regulation of Food Intake: A Systematic Review (02 Sep 2024)
  
• Research progress on the cannabinoid type-2 receptor and Parkinson’s disease (02 Sep 2024)
  
• Prenatal cannabinoid exposure: why expecting individuals should take a pregnancy pause from using cannabinoid products (02 Sep 2024)
  
• Motifs in Natural Products as Useful Scaffolds to Obtain Novel Benzo[d]imidazole-Based Cannabinoid Type 2 (CB2) Receptor Agonists (02 Sep 2024)
  
• Molecular Advances on Cannabinoid and Endocannabinoid Research (02 Sep 2024)
  
• Hemp Seed Oil Inhibits the Adipogenicity of the Differentiation-Induced Human Mesenchymal Stem Cells through Suppressing the Cannabinoid Type 1 (CB1) (02 Sep 2024)
  
• Expression of Cannabinoid Receptors in the Trigeminal Ganglion of the Horse (02 Sep 2024)
  
• Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity (02 Sep 2024)
  
• Editorial: Insights on cannabinoid translational science and medicine: the endocannabinoidome as a target for clinical practice (02 Sep 2024)
  
• Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation (02 Sep 2024)
  
• Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease (02 Sep 2024)
  
• Cannabinoid Analgesia in Postoperative Pain Management: From Molecular Mechanisms to Clinical Reality (02 Sep 2024)
  
• A collection of cannabinoid-related negative findings from autaptic hippocampal neurons (30 Aug 2024)
  
• The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Colon Cancer: A Study in Mice and Humans (29 Aug 2024)
  
• Role of neuronal nicotinic acetylcholine receptors in cannabinoid dependence ☆ (29 Aug 2024)
  
• Neuronal Cannabinoid CB1 Receptors Suppress the Growth of Melanoma Brain Metastases by Inhibiting Glutamatergic Signalling (29 Aug 2024)
  
• Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms (29 Aug 2024)
  
• Cannabinoid-Based Ocular Therapies and Formulations (29 Aug 2024)
  
• Role of Endo-opioid and Endo-cannabinoid Systems in Migraine and Medication-overuse Headache (28 Aug 2024)
  
• Exploring the Potential of Cannabinoid Nanodelivery Systems for CNS Disorders (28 Aug 2024)
  
• Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases (28 Aug 2024)
  
• Voltage dependence of the cannabinoid CB1 receptor (27 Aug 2024)
  
• Therapeutic Use of Cannabis in Inflammatory Bowel Disease (27 Aug 2024)
  
• The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease (27 Aug 2024)
  
• The Enteric Glia and Its Modulation by the Endocannabinoid System, a New Target for Cannabinoid-Based Nutraceuticals? (27 Aug 2024)
  
• Molecular Insights into Epigenetics and Cannabinoid Receptors (27 Aug 2024)
  
• Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease (25 Aug 2024)
  
• The cannabinoid receptors system in horses: Tissue distribution and cellular identification in skin (25 Aug 2024)
  
• Cannabinoid CB1 receptors regulate salivation (25 Aug 2024)
  
• Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration (25 Aug 2024)
  
• A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ (25 Aug 2024)
  
• New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders (21 Aug 2024)
  
• Interplay between the Cannabinoid System and microRNAs in Cancer (21 Aug 2024)
  
• Impact of Cannabinoid Compounds on Skin Cancer (21 Aug 2024)
  
• Therapeutic potential of the cannabinoid receptor 2 in neuropsychiatry (20 Aug 2024)
  
• The Treatment of Cognitive, Behavioural and Motor Impairments from Brain Injury and Neurodegenerative Diseases through Cannabinoid System Modulation—Evidence from In Vivo Studies (20 Aug 2024)
  
• Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products (20 Aug 2024)
  
• Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies (20 Aug 2024)
  
• Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting (20 Aug 2024)
  
• Metabolic Consequences of Gestational Cannabinoid Exposure (20 Aug 2024)
  
• Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response (20 Aug 2024)
  
• Cannabinoid Signaling in Auditory Function and Development (20 Aug 2024)
  
• Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease (20 Aug 2024)
  
• Cannabinoid Modulation of Dopamine Release During Motivation, Periodic Reinforcement, Exploratory Behavior, Habit Formation, and Attention (20 Aug 2024)
  
• Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson’s Disease (19 Aug 2024)
  
• Interaction between cannabinoid and nucleotide systems as a new mechanism of signaling in retinal cell death (19 Aug 2024)
  
• Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System (19 Aug 2024)
  
• Cannabinoid Delivery Systems for Pain and Inflammation Treatment (19 Aug 2024)
  
• Antitumor Cannabinoid Chemotypes: Structural Insights (19 Aug 2024)
  
• Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges (18 Aug 2024)
  
• Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system (18 Aug 2024)
  
• Modulation of breast cancer cell viability by a cannabinoid receptor 2 (18 Aug 2024)
  
• Focus on the Endogenous Cannabinoid System in Migraine (18 Aug 2024)
  
• CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease (18 Aug 2024)
  
• Cannabinoid Modulation of the Stressed Hippocampus (18 Aug 2024)
  
• Cannabinoid CB1 Receptors Are Localized in Striated Muscle Mitochondria and Regulate Mitochondrial Respiration (18 Aug 2024)
  
• Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy (18 Aug 2024)
  
• Interaction between Cannabinoid System and Toll-Like Receptors Controls Inflammation (12 Aug 2024)
  
• Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (12 Aug 2024)
  
• Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer (24 May 2024)
  
• Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy (13 May 2024)
  
• Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update (27 Feb 2023)
  
• Endocannabinoid System: Chemical Characteristics and Biological Activity (27 Feb 2023)
  
• Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review (27 Feb 2023)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists (05 Sep 2022)
  
• Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors? (05 Sep 2022)
  
• Kahweol, a natural diterpene from coffee, induces peripheral antinociception by endocannabinoid system activation (05 Sep 2022)
  
• The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders (01 Sep 2022)
  
• Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression (27 Aug 2022)
  
• New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence (27 Aug 2022)
  
• Considerations for Cannabinoids in Perioperative Care by Anesthesiologists (13 Aug 2022)
  
• Components of the Endocannabinoid System and Effects of Cannabinoids Against Bone Diseases: A Mini-Review (13 Aug 2022)
  
• The Mediterranean Diet as a Source of Bioactive Molecules with Cannabinomimetic Activity in Prevention and Therapy Strategy (07 Aug 2022)
  
• Cannabinoids, their cellular receptors, and effects on the invasive phenotype of carcinoma and metastasis (05 Aug 2022)
  
• CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature - Journal of Cannabis Research (26 Jul 2022)
  
• Endocannabinoid System and Migraine Pain: An Update (25 Jul 2022)
  
• Research Breakthrough: Cannabis & Autism (21 Jul 2022)
  
• Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review (21 Jul 2022)
  
• Endocannabinoid Discovery Timeline (21 Jul 2022)
  
• What Is CBC Oil Good For? Benefits, Uses, & Effects (18 Jul 2022)